10 years of Cre8™ legacy

WE ARE ALVIMEDICA

WORLD LEADING QUALITY

LIVING INNOVATION

BETTER OUTCOMES FOR PATIENTS

The patented polymer free technology – based on abluminal reservoirs precisely controlling the Amphilimus™ formulation release – has been CE approved 10 years ago.
News

A global manufacturer of unique interventional medical devices, harnessing the power of innovation to improve our patient’s quality of life. We tackle today’s toughest patients clinical conditions by creating innovative products.
About

We create the highest quality products, trusted by leading professionals around the world.
Quality

Our driving passion is to improve the quality of life through innovative technology, creating a better future by investing in both clinical research and product development.
Products

Alvimedica is committed to improving patient outcomes, as well as tackling global issues such as Diabetes, which we are 100% committed to defeating.
Products

PRODUCTS

DIABETES

WORKING FOR
DIABETES
PROJECTS

Diabetes is a number of diseases that involve
problems with hormone insulin.
Normally...

NEWS

10 years of Cre8™ legacy

Alvimedica Announces the CE Mark approval of the new polymer free self expanding Amphilimus eluting DES for SFA lesions, NiTiDES™

Alvimedica @ the EuroPCR 2021: “Empowering DES performance in complex patients to maximise efficacy and safety outcomes"

DISCOVER